Nucleic acid testing identifies high prevalence of blood borne viruses among approved blood donors in Mozambique

Bibliographic Details
Main Author: Mabunda, Nédio
Publication Date: 2022
Other Authors: Augusto, Orvalho, Zicai, Ana Flora, Duajá, Ana, Oficiano, Sandra, Ismael, Nalia, Vubil, Adolfo, Mussá, Tufária, Moraes, Milton Ozório, Jani, Ilesh
Format: Article
Language: eng
Source: Repositório Institucional da FIOCRUZ (ARCA)
DOI: 10.1371/journal.pone.0267472
Download full: https://arca.fiocruz.br/handle/icict/54586
Summary: Produção científica do Laboratório de Hanseníase.
id CRUZ_8d6f96ffae0565d17be484a380e541e3
oai_identifier_str oai:arca.fiocruz.br:icict/54586
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Mabunda, NédioAugusto, OrvalhoZicai, Ana FloraDuajá, AnaOficiano, SandraIsmael, NaliaVubil, AdolfoMussá, TufáriaMoraes, Milton OzórioJani, Ilesh2022-08-11T12:03:10Z2022-08-11T12:03:10Z2022MABUNDA, Nédio et al. Nucleic acid testing identifies high prevalence of blood borne viruses among approved blood donors in Mozambique. PLoS ONE, v. 17, n. 4, p. 1-12, 28 Apr. 2022.1932-6203https://arca.fiocruz.br/handle/icict/5458610.1371/journal.pone.02674721932-6203Produção científica do Laboratório de Hanseníase.Instituto Nacional de Saúde. Marracuene, Mozambique / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.Universidade Eduardo Mondlane. Faculdade de Medicina. Maputo, Mozambique.Instituto Nacional de Saúde. Marracuene, Mozambique.Instituto Nacional de Saúde. Marracuene, Mozambique / Hospital Central da Beira. Sofala, Mozambique.Hospital Central de Maputo. Maputo, Mozambique.Instituto Nacional de Saúde. Marracuene, Mozambique.Instituto Nacional de Saúde. Marracuene, Mozambique.Universidade Eduardo Mondlane. Faculdade de Medicina. Maputo, Mozambique.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hanseníase. Rio de Janeiro, RJ, Brasil.Instituto Nacional de Saúde. Marracuene, Mozambique.Background: Although blood transfusion is an intervention that saves lives, it poses significant risks to the blood receivers, including the transmission of bloodborne pathogens. We aimed at determining the prevalence of Human Immunodeficiency Virus (HIV), Hepatitis B virus (HBV), and Hepatitis C virus (HCV) in candidates approved for blood donation, and in samples considered to be negative in reference blood banks in Mozambique. Methods: A cross-sectional study was performed between November 2014 and October 2015 in Maputo and Beira cities. Demographic information was obtained from all consenting blood donors using a structured questionnaire. Plasma samples were screened for HIVAb/Ag combinations, HBsAg and Anti-HCV. Blood donors considered to be negative by serological testing were re-tested in pools of six plasma samples using nucleic acid testing (NAT). Results: Most blood donors were male 2,320 (83.4%) with an age range of 18 to 34 years. The overall seroprevalence of HIV, HBV and HCV infections among blood donors approved for donation was 4.6% (127; 95% CI 3.8–5.4), 4.5% (124; 95% CI 3.7–5.3) and 0.4% (11; 95% CI 0.2–0.7), respectively. The overall frequency by NAT of HIV RNA, HBV DNA, and HCV RNA in serologically negative blood donor samples was 2.6 per 1000 blood donors (7; 95% CI 1.1–5.4); 12.5 per 1000 blood donors (33; 95% CI 8.6–17.5) and 2.6 per 1000 blood donors (6; 95% CI 1.0–5.7), respectively. Conclusion: Our results show high seroprevalence of HIV and HBV infections in blood donors approved for donation, and high frequency of molecular biomarkers of HIV, HBV, and HCV in blood considered to be safe. These results suggest the need for a new blood screening policy in Mozambique, including the use of NAT to detect infectious blood donations during the immunologically negative window.engPublic Library of ScienceNucleic acid testing identifies high prevalence of blood borne viruses among approved blood donors in Mozambiqueinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleBlood donorsHIVVirus testingSerologyHepatitis B virusMedical risk factorsBlood banksMozambiqueinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://arca.fiocruz.br/bitstreams/b9df632e-72e0-43ae-b798-db79e354b894/download5a560609d32a3863062d77ff32785d58MD51falseAnonymousREADORIGINALMiltonMoraes_NedioMabunda_etal_IOC_2022.pdfMiltonMoraes_NedioMabunda_etal_IOC_2022.pdfapplication/pdf645077https://arca.fiocruz.br/bitstreams/af7c19c8-3ba5-4e6e-bcb5-9c5bc0e7ea10/download9f390a27c7e066784ac2070c211399eaMD52trueAnonymousREADTHUMBNAILcapa_Nedio_Mabunda_etal_IOC_2022.jpgcapa_Nedio_Mabunda_etal_IOC_2022.jpgCapaimage/jpeg2085610https://arca.fiocruz.br/bitstreams/d7b50ffc-3f84-4918-8d5f-8dc24c63a8a9/download3d91681c118f124c62b93cb795873861MD53falseAnonymousREADMiltonMoraes_NedioMabunda_etal_IOC_2022.pdf.jpgMiltonMoraes_NedioMabunda_etal_IOC_2022.pdf.jpgGenerated Thumbnailimage/jpeg5746https://arca.fiocruz.br/bitstreams/456a3b84-c288-4e9f-bbbe-e4a8b5046c38/downloadc5a1df286acb7a23b2bc860cf3dd8a6aMD57falseAnonymousREADTEXTMiltonMoraes_NedioMabunda_etal_IOC_2022.pdf.txtMiltonMoraes_NedioMabunda_etal_IOC_2022.pdf.txtExtracted texttext/plain44465https://arca.fiocruz.br/bitstreams/0bd4e7d8-0dbf-4632-941b-a2637a420ac2/downloada4bbbe1ad65b88e49506812e7ec862adMD56falseAnonymousREADicict/545862025-07-30 02:39:02.447open.accessoai:arca.fiocruz.br:icict/54586https://arca.fiocruz.brRepositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352025-07-30T05:39:02Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)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
dc.title.none.fl_str_mv Nucleic acid testing identifies high prevalence of blood borne viruses among approved blood donors in Mozambique
title Nucleic acid testing identifies high prevalence of blood borne viruses among approved blood donors in Mozambique
spellingShingle Nucleic acid testing identifies high prevalence of blood borne viruses among approved blood donors in Mozambique
Mabunda, Nédio
Blood donors
HIV
Virus testing
Serology
Hepatitis B virus
Medical risk factors
Blood banks
Mozambique
title_short Nucleic acid testing identifies high prevalence of blood borne viruses among approved blood donors in Mozambique
title_full Nucleic acid testing identifies high prevalence of blood borne viruses among approved blood donors in Mozambique
title_fullStr Nucleic acid testing identifies high prevalence of blood borne viruses among approved blood donors in Mozambique
title_full_unstemmed Nucleic acid testing identifies high prevalence of blood borne viruses among approved blood donors in Mozambique
title_sort Nucleic acid testing identifies high prevalence of blood borne viruses among approved blood donors in Mozambique
author Mabunda, Nédio
author_facet Mabunda, Nédio
Augusto, Orvalho
Zicai, Ana Flora
Duajá, Ana
Oficiano, Sandra
Ismael, Nalia
Vubil, Adolfo
Mussá, Tufária
Moraes, Milton Ozório
Jani, Ilesh
author_role author
author2 Augusto, Orvalho
Zicai, Ana Flora
Duajá, Ana
Oficiano, Sandra
Ismael, Nalia
Vubil, Adolfo
Mussá, Tufária
Moraes, Milton Ozório
Jani, Ilesh
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Mabunda, Nédio
Augusto, Orvalho
Zicai, Ana Flora
Duajá, Ana
Oficiano, Sandra
Ismael, Nalia
Vubil, Adolfo
Mussá, Tufária
Moraes, Milton Ozório
Jani, Ilesh
dc.subject.en.none.fl_str_mv Blood donors
HIV
Virus testing
Serology
Hepatitis B virus
Medical risk factors
Blood banks
Mozambique
topic Blood donors
HIV
Virus testing
Serology
Hepatitis B virus
Medical risk factors
Blood banks
Mozambique
description Produção científica do Laboratório de Hanseníase.
publishDate 2022
dc.date.accessioned.fl_str_mv 2022-08-11T12:03:10Z
dc.date.available.fl_str_mv 2022-08-11T12:03:10Z
dc.date.issued.fl_str_mv 2022
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv MABUNDA, Nédio et al. Nucleic acid testing identifies high prevalence of blood borne viruses among approved blood donors in Mozambique. PLoS ONE, v. 17, n. 4, p. 1-12, 28 Apr. 2022.
dc.identifier.uri.fl_str_mv https://arca.fiocruz.br/handle/icict/54586
dc.identifier.issn.none.fl_str_mv 1932-6203
dc.identifier.doi.none.fl_str_mv 10.1371/journal.pone.0267472
dc.identifier.eissn.none.fl_str_mv 1932-6203
identifier_str_mv MABUNDA, Nédio et al. Nucleic acid testing identifies high prevalence of blood borne viruses among approved blood donors in Mozambique. PLoS ONE, v. 17, n. 4, p. 1-12, 28 Apr. 2022.
1932-6203
10.1371/journal.pone.0267472
url https://arca.fiocruz.br/handle/icict/54586
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Public Library of Science
publisher.none.fl_str_mv Public Library of Science
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://arca.fiocruz.br/bitstreams/b9df632e-72e0-43ae-b798-db79e354b894/download
https://arca.fiocruz.br/bitstreams/af7c19c8-3ba5-4e6e-bcb5-9c5bc0e7ea10/download
https://arca.fiocruz.br/bitstreams/d7b50ffc-3f84-4918-8d5f-8dc24c63a8a9/download
https://arca.fiocruz.br/bitstreams/456a3b84-c288-4e9f-bbbe-e4a8b5046c38/download
https://arca.fiocruz.br/bitstreams/0bd4e7d8-0dbf-4632-941b-a2637a420ac2/download
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
9f390a27c7e066784ac2070c211399ea
3d91681c118f124c62b93cb795873861
c5a1df286acb7a23b2bc860cf3dd8a6a
a4bbbe1ad65b88e49506812e7ec862ad
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1839716471217848320